LEEANNA PETERSON: Open Payments
NPI 1669821112 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,236 in 117 payments from 30 companies in 2025. Trend: 2023 $1,343 · 2024 $2,568 · 2025 $2,236
Food & beverage: $2,236
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $235 |
| Novo Nordisk Inc | 18 | $222 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $183 |
| BETA BIONICS, INC. | 7 | $171 |
| Lilly USA, LLC | 10 | $164 |
| Insulet Corporation | 10 | $163 |
| SANOFI-AVENTIS U.S. LLC | 5 | $145 |
| Amneal Pharmaceuticals LLC | 5 | $90 |
| Abbott Laboratories | 4 | $83 |
| ABBVIE INC. | 4 | $81 |
Products named: Kerendia, iLet Bionic Pancreas, Omnipod, REPATHA, TZIELD, Ozempic, UNITHROID, TEPEZZA.
Industry payments across AZ — which companies pay providers there.
